Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

170results about How to "Less reactive" patented technology

Modified Molecular Arrays

The invention relates to the preparation of a hydrogel surface useful in the formation and manipulation of arrays of molecules, particularly polynucleotides and to the chemical modification of these and other arrays. In particular, the invention relates to a method of preparing a hydrogel immobilised to a solid support comprising polymerising on the support a mixture of a first comonomer which is acrylamide, methacrylamide, hydroxyethyl methacrylate or N-vinyl pyrrolidinone and a second comonomer which is a functionalised acrylamide or acrylate.
Owner:ILLUMINA CAMBRIDGE LTD

Polymerization in the presence of a beta-substituted nitroxide radical

The invention relates to a process for the polymerization or copolymerization of at least one monomer which is polymerizable by the radical route in the presence of a stable free radical from the nitroxide family. The stable free radical is beta-substituted and provides excellent control of polydispersity while ensuring a better rate of polymerization or copolymerization, if they are compared with the stable free radicals used in the prior art.
Owner:ELF ATOCHEM SA

Permanent fixation of dyes to surface-modified inorganic particulate-coated media

Systems and methods for producing permanent ink-jet images are provided. In one embodiment, a system comprises a media substrate coated with a porous media coating, wherein the porous media coating comprises inorganic porous particulates, and wherein at least a portion of the inorganic porous particulates have a first reactive group covalently attached thereto. The system further includes an ink-jet ink containing a dye, wherein the dye comprises a second reactive group, and wherein the first reactive group and the second reactive group are configured to react with one another upon contact to form a covalent bond. In an alternative embodiment, a method of producing permanent ink-jet images can comprise the steps of covalently bonding a first reactive group to an inorganic porous particulate; coating the inorganic porous particulate onto a media substrate to form a coated media substrate; ink-jetting a dye-containing ink-jet ink composition onto the coated media substrate, wherein the dye includes a second reactive group. The first reactive group and the second reactive group, upon contact, can interact to form a covalent bond.
Owner:HEWLETT PACKARD DEV CO LP

Coated article with ion treated overcoat layer and corresponding method

A coated article is provided that may be used as a vehicle windshield, insulating glass (IG) window unit, or the like. Ion beam treatment is performed on a layer(s) of the coating. For example, an overcoat layer (e.g., of silicon nitride) of a low-E coating may be ion beam treated in a manner so as to cause the ion beam treated layer to include (a) nitrogen-doped Si3N4, and / or (b) nitrogen graded silicon nitride. It has been found that this permits durability of the coated article to be improved.
Owner:GUARDIAN GLASS LLC

Method for end-capping polycarbonate resins and composition for use in same

A method for end-capping polycarbonate resins, comprising the step of processing a mixture comprising a polycarbonate having free hydroxyl-end groups and an end-capping reagent in a melt transesterification reaction to produce a polycarbonate resin, wherein the end-capping reagent comprises a mixture of: (a) at least one species of a symmetrical activated aromatic carbonate, and (b) at least one species of an optionally-substituted phenol, whereby said end-capping reagent reacts with at least some of the free hydroxyl end-groups of the polycarbonate to produce an end-capped polycarbonate resin.
Owner:SABIC GLOBAL TECH BV

Device and method for tacking plaque to blood vessel wall

ActiveUS20090157159A1Few structuresLimiting bending stressStentsBlood vesselsBalloon dilatationAnchor point
A plaque tack device for treating atherosclerotic occlusive disease is formed as a thin, annular band of durable, flexible material having a plurality of barbs or anchoring points on its outer periphery for preventing it from being dislodged. The plaque tack may be used with a balloon angioplasty procedure or as a de novo treatment for blood vessel blockage to reopen the vessel lumen for desired blood flow. It has a width that is small relative to its diameter, to minimize the amount of foreign structure placed in the blood vessel. One or more tacks may be applied in positions along a plaque accumulation site as needed to stabilize the site and / or hold pieces of plaque out of the way of blood flow. The barbs of the tack may be pressed into the plaque and / or blood vessel walls by balloon expansion. Related methods of deployment and delivery devices are provided for insertion of the plaque tack in a compressed state into the blood vessel and expanding it back to its annular shape for holding plaque against the blood vessel walls.
Owner:INTACT VASCULAR

Certain polyester compositions which comprise cyclohexanedimethanol, moderate cyclobutanediol, cyclohexanedimethanol, and high trans cyclohexanedicarboxylic acid

Described as one aspect of the invention are polyester compositions A polyester composition comprising at least one polyester which comprises:(A) a dicarboxylic acid component comprising:i) 70 to 100 mole % of cyclohexanedicarboxylic acid residues or an ester thereof comprising:(a) 80 to 99 mole % trans-cyclohexanedicarboxylic acid residues or an ester thereof; and(b) 1 to 20 mole % cis-cyclohexanedicarboxylic acid residues or an ester thereof;ii) 0 to 30 mole % of aliphatic dicarboxylic acid residues, other than cyclohexanedicarboxylic acid residues, having up to 16 carbon atoms or esters thereof, other than cyclohexanedicarboxylic acid residues; andiii) 0 to 10 mole % of aromatic dicarboxylic acid residues having up to 20 carbon atoms; and(B) a glycol component comprising:i) 5 to 35 mole % of 2,2,4,4-tetramethyl-1,3-cyclobutanediol residues; andii) 65 to 95 mole % of 1,4-cyclohexanedimethanol residues, 1,3-cyclohexanedimethanol residues, 1,2-cyclohexanedimethanol residues or esters thereof or mixtures thereof,wherein the total mole % of said dicarboxylic acid component is equal to 100 mole %;the total mole % of said glycol component is equal to 100 mole %;wherein the inherent viscosity of said polyester is from 0.35 to 1.2 dL / g as determined in 60 / 40 (wt / wt) phenol / tetrachloroethane at a concentration of 0.5 g / 100 ml at 25° C.; and wherein said polyester has a Tg of from 66 to 120° C. The polyesters may be manufactured into articles.
Owner:EASTMAN CHEM CO

Injectable hyaluronic acid derivative with pharmaceuticals/cells

Disclosed is an injectable, biocompatible and biodegradable composition, comprising at least one hyaluronic acid benzyl ester or auto-cross-linked derivative, in combination with at least one mammalian cell and / or at least one pharmacologically or biologically active substance and / or micro-particles such as fibres, granules, microspheres or sponge fragments of a hyaluronic acid derivative.
Owner:ANIKA THERAPEUTICS SRL

Method for the preparation of controlled release formulations

The methods disclosed herein are of use for the production of controlled release compositions. In particular, the methods provide the contacting of an organic phase containing a bioactive agent and a polymer with an aqueous phase containing an organic ion to create controlled release compositions containing bioactive agents. The present invention also includes controlled release compositions including a polymer, an organic ion and a bioactive agent. The present invention also includes methods of using such controlled release compositions. The usefulness of the present invention is that the methods result in the production of controlled release compositions containing bioactive agent capable of administration in a concentrated low-dose form, having low burst and reduced production of degraded bioactive agent.
Owner:PR PHARMA +1

Devices and methods for the delivery of blood clotting materials to bleeding wounds

An apparatus for promoting the clotting of blood and controlling bleeding comprises a receptacle for retaining blood clotting material in particulate form therein. A pad for controlling bleeding comprises a mesh structure and a support attached to the mesh structure to facilitate the application of pressure to the pad and the wound. A bandage applicable to a bleeding wound comprises a mesh structure and a flexible substrate attached to the mesh structure, the substrate being a cloth or plastic member that may be adhesively attachable to cover a wound. In any embodiment, at least a portion of the receptacle or mesh structure is defined by a mesh having openings therein, and at least a portion of the particulate blood clotting material is in direct contact with blood. The mesh may include a zeolite powder impregnated or otherwise incorporated therein.
Owner:TELEFLEX LIFE SCI LTD

Coated article with ion treated underlayer and corresponding method

A coated article is provided that may be used as a vehicle windshield, insulating glass (IG) window unit, or the like. Ion beam treatment is performed on a layer(s) of the coating. For example, a silicon nitride layer of a low-E coating may be ion beam treated. It has been found that ion beam treatment, for example, of a silicon nitride underlayer is advantageous in that sodium migration from the glass substrate toward the IR reflecting layer(s) can be reduced during heat treatment.
Owner:GUARDIAN GLASS LLC

Ink formulations comprising gallium naphthalocyanines

There is provided an aqueous formulation comprising an IR-absorbing naphthalocyanine dye of formula (II):or a salt form thereof, wherein:M is Ga(A1);A1 is an axial ligand selected from —OH, halogen, —OR3, —OC(O)R4 or —O(CH2CH2O)eRe wherein e is an integer from 2 to 10 and Re is H, C1-8 alkyl or C(O)C1-8 alkyl;R1 and R2 may be the same or different and are selected from hydrogen or C1-12 alkoxy;R3 is selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl or Si(Rx)(Ry)(Rz);R4 is selected from C1-12 alkyl, C5-12 aryl or C5-12 arylalkyl; andRx, Ry and Rz may be the same or different and are selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl, C1-12 alkoxy, C5-12 aryloxy or C5-12 arylalkoxy;The formulation has a pH in the range of 3.5 to 7 and is particularly suitable for use as an IR-absorbing inkjet ink, providing compatibility with known CMYK inks together with an optimally red-shifted λmax.
Owner:BASF AG

Controlled released compositions

The compositions disclosed herein are for use as controlled release therapeutics for the treatment of a wide variety of diseases. In particular, the compositions provide water soluble bioactive agents, organic ions and polymers where the bioactive agent is efficiently released over time with minimal degradation products. The resulting controlled release composition is capable of administration in a decreased dose volume due to the high drug content and predominance of non-degraded bioactive agent after release. Additionally, the compositions, of the present invention are capable of long term, sustained releases.
Owner:PR PHARMA +1

Certain polyester compositions which comprise cyclobutanediol, cyclohexanedimethanol, and high trans-cyclohexanedicarboxylic acid

InactiveUS20070232778A1Easily or more expensively stabilizedLess expensivePolyesterTetrachloroethane
Described as one aspect of the invention are polyester compositions comprising at least one polyester which comprises:(A) a dicarboxylic acid component comprising:i) 70 to 100 mole % of cyclohexanedicarboxylic acid residues or an ester thereof comprising:(a) 70 to 98 mole % trans-cyclohexanedicarboxylic acid residues or an ester thereof; and(b) 2 to 30 mole % cis-cyclohexanedicarboxylic acid residues or an ester thereof;ii) 0 to 30 mole % of aliphatic dicarboxylic acid residues, other than cyclohexanedicarboxylic acid residues, having up to 16 carbon atoms or esters thereof, other than cyclohexanedicarboxylic acid residues,; andiii) 0 to 10 mole % of aromatic dicarboxylic acid residues having up to 20 carbon atoms; and(B) a glycol component comprising:i) 1 to 99 mole % of 2,2,4,4-tetramethyl-1,3-cyclobutanediol residues; andii) 1 to 99 mole % of 1,4-cyclohexanedimethanol residues, 1,3-cyclohexanedimethanol residues, 1,2-cyclohexanedimethanol residues or esters thereof or mixtures thereof,wherein the total mole % of said dicarboxylic acid component is equal to 100 mole %;the total mole % of said glycol component is equal to 100 mole %;wherein the inherent viscosity of said polyester is from 0.35 to 1.2 dL / g as determined in 60 / 40 (wt / wt) phenol / tetrachloroethane at a concentration of 0.5 g / 100 ml at 25° C.; and wherein said polyester has a Tg of from 60 to 155° C. The polyesters may be manufactured into articles.
Owner:EASTMAN CHEM CO

Water-soluble polymer alkanals

The present invention is directed to alkanal derivatives of water-soluble polymers such as poly(ethylene glycol), their corresponding hydrates and acetals, and to methods for preparing and using such polymer alkanals. The polymer alkanals of the invention are prepared in high purity and exhibit storage stability.
Owner:NEKTAR THERAPEUTICS INC

Water-soluble polymer alkanals

The present invention is directed to alkanal derivatives of water-soluble polymers such as poly(ethylene glycol), their corresponding hydrates and acetals, and to methods for preparing and using such polymer alkanals. The polymer alkanals of the invention are prepared in high purity and exhibit storage stability.
Owner:NEKTAR THERAPEUTICS INC

Selective hydrogenation of unsaturated aliphatic hydrocarbons in predominantly aromatic streams

The selective saturation of unsaturated aliphatic hydrocarbons (e.g., diolefins) in a hydrogenation feed stream comprising an aromatic compound (e.g., benzene) and one or more nitrogen compounds renders is beneficial when the stream or a portion thereof is subsequently treated (e.g., with a zeolitic adsorbent) to remove nitrogen. In particular, the selective saturation of, for example, olefins and diolefins prolongs the life of the nitrogen guard bed. In a representative embodiment, the selective hydrogenation is applied to a recycle benzene-containing stream recovered in the separation section (e.g., from the benzene / toluene splitter overhead) of a styrene production process, prior to treatment with a nitrogen guard bed adsorbent.
Owner:UOP LLC

Metallization structure on a fluorine-containing dielectric and a method for fabrication thereof

The present invention is related to a metallization structure on a fluorine-containing dielectric and a method for fabrication thereof. This metallization structure comprises a conductive pattern; a fluorine-containing dielectric; and a barrier layer containing a material, i.e. a near noble metal such as Co, Ni, Pt and Pd, said barrier layer comprising at least a first part, being positioned between said fluorine-containing dielectric and said conductive pattern, said first part containing at least a first and a second sub-layer, said first sub-layer contacting said fluorine-containing dielectric and being impermeable for fluorine. Particularly by depositing a layer of said material on a fluorine-containing dielectric, a stable and thin layer of a fluoride of said material is formed in a self-limiting way.
Owner:INTERUNIVERSITAIR MICRO ELECTRONICS CENT (IMEC VZW)

Gallium naphthalocyanine salts for use as improved infrared dyes

There is provided an IR-absorbing naphthalocyanine dye of formula (I):whereinM is Ga(A1);A1 is an axial ligand selected from —OH, halogen, —OR3, —OC(O)R4 or —O(CH2CH2O)eRe wherein e is an integer from 2 to 10 and Re is H, C1-8 alkyl or C(O)C1-8 alkyl;R1 and R2 may be the same or different and are selected from hydrogen or C1-12 alkoxy;R3 is selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl or Si(Rx)(Ry)(Rz);R4 is selected from C1-12 alkyl, C5-12 aryl or C5-12 arylalkyl;Rx, Ry and Rz may be the same or different and are selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl, C1-12 alkoxy, C5-12 aryloxy or C5-12 arylalkoxy; andeach B is independently selected from a base, wherein BH+ has a pKa of between 4 and 9. The dye is suitable for use in IR-absorbing inkjet inks, providing compatibility with known CMYK inks together with an optimally red-shifted λmax.
Owner:BASF SE

Electron device having electrode made of metal that is familiar with carbon

An electronic device having an electrode made of metal that reacts easily with carbon is provided. In the electronic device, the electrode on which carbon nanotubes are deposited by a chemical vapor deposition method using a reactant gas containing carbon and oxygen, is made of a metal generating less reaction enthalpy when reacting with carbon than when reacting with oxygen. Since the electrode is made of a metal which reacts with carbon faster than oxygen, a carbonized metal layer is formed on the electrode, thereby preventing the electrode from being oxidized. Accordingly, the carbon nanotubes can be easily deposited on the electrode.
Owner:SAMSUNG SDI CO LTD

Medical device including unitary, continuous portion of varying durometer

InactiveUS6881209B2Improved combination of strengthPrevent restenosisLaminationLamination apparatusPolyesterCross-link
A medical device (110) including a catheter shaft (111) and a unitarily and continuously formed portion (108) having a varying durometer, and optionally including an expandable balloon (18, 118). One or both of the unitarily and continuously formed portion (108) and the balloon (18, 118) are made from an irradiation cross-linked or cross-linkable mixture of a polyamide elastomer and at least one additional cross-linking reactant. The polyamide elastomer can be a polyester amide, a polyether ester amide or a polyether amide, and is preferably a nylon block copolymer. The aromatic molecule can be 1,3,5 triethyl benzene; 1,2,4 triethyl benzene; and 1,3,5 triisopropyl benzene. The cross-linking reactant can be: (a) a difunctional material, (b) a trifunctional material, (c) a tetrafunctional material, or (d) an aromatic molecule containing at least two ring substituents, each of the ring substituents having labile hydrogens at a benzylic site therein. The cross-linking reactant can also be diallyl phthalate or meta-phenylene dimaleimide.
Owner:COOK MEDICAL TECH LLC

Ink formulations comprising gallium naphthalocyanines

There is provided an aqueous formulation comprising an IR-absorbing naphthalocyanine dye of formula (II):or a salt form thereof, wherein:M is Ga(A1);A1 is an axial ligand selected from —OH, halogen, —OR3, —OC(O)R4 or —O(CH2CH2O)eRe wherein e is an integer from 2 to 10 and Re is H, C1-8 alkyl or C(O)C1-8 alkyl;R1 and R2 may be the same or different and are selected from hydrogen or C1-12 alkoxy;R3 is selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl or Si(Rx)(Ry)(Rz);R4 is selected from C1-12 alkyl, C5-12 aryl or C5-12 arylalkyl; andRx, Ry and Rz may be the same or different and are selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl, C1-12 alkoxy, C5-12 aryloxy or C5-12 arylalkoxy;The formulation has a pH in the range of 3.5 to 7 and is particularly suitable for use as an IR-absorbing inkjet ink, providing compatibility with known CMYK inks together with an optimally red-shifted λmax.
Owner:BASF SE

Medical device including unitary, continuous portion of varying durometer

A medical device (110) including a catheter shaft (111) and a unitarily and continuously formed portion (108) having a varying durometer, and optionally including an expandable balloon (18, 118). One or both of the unitarily and continuously formed portion (108) and the balloon (18, 118) are made from an irradiation cross-linked or cross-linkable mixture of a polyamide elastomer and at least one additional cross-linking reactant. The polyamide elastomer can be a polyester amide, a polyether ester amide or a polyether amide, and is preferably a nylon block copolymer. The aromatic molecule can be 1,3,5 triethyl benzene; 1,2,4 triethyl benzene; and 1,3,5 triisopropyl benzene. The cross-linking reactant can be: (a) a difunctional material, (b) a trifunctional material, (c) a tetrafunctional material, or (d) an aromatic molecule containing at least two ring substituents, each of the ring substituents having labile hydrogens at a benzylic site therein. The cross-linking reactant can also be diallyl phthalate or meta-phenylene dimaleimide.
Owner:COOK MEDICAL TECH LLC

Gallium naphthalocyanine salts for use as improved infrared dyes

There is provided an IR-absorbing naphthalocyanine dye of formula (I):whereinM is Ga(A1);A1 is an axial ligand selected from —OH, halogen, —OR3, —OC(O)R4 or —O(CH2CH2O)eRe wherein e is an integer from 2 to 10 and Re is H, C1-8 alkyl or C(O)C1-8 alkyl;R1 and R2 may be the same or different and are selected from hydrogen or C1-12 alkoxy;R3 is selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl or Si(Rx)(Ry)(Rz);R4 is selected from C1-12 alkyl, C5-12 aryl or C5-12 arylalkyl;Rx, Ry and Rz may be the same or different and are selected from C1-12 alkyl, C5-12 aryl, C5-12 arylalkyl, C1-12 alkoxy, C5-12 aryloxy or C5-12 arylalkoxy; andeach B is independently selected from a base, wherein BH+ has a pKa of between 4 and 9.The dye is particularly suitable for use in IR-absorbing inkjet inks, providing compatibility with known CMYK inks together with an optimally red-shifted λmax.
Owner:BASF AG

Method for end-capping polycarbonate resins and composition for use in same

A method for end-capping polycarbonate resins, comprising the step of processing a mixture comprising a polycarbonate having free hydroxyl-end groups and an end-capping reagent in a melt transesterification reaction to produce a polycarbonate resin, wherein the end-capping reagent comprises a mixture of:(a) at least one species of a symmetrical activated aromatic carbonate, and (b) at least one species of an optionally-substituted phenol, whereby said end-capping reagent reacts with at least some of the free hydroxyl end-groups of the polycarbonate to produce an end-capped polycarbonate resin.
Owner:SABIC GLOBAL TECH BV

Semi-aromatic polyamide PA11T and preparation method thereof

ActiveCN104817693AHigh molecular weightHigh temperature high molecular weightPolymer scienceMaterial synthesis
The invention discloses a semi-aromatic polyamide PA11T and a synthetic method thereof and belongs to the technical field of high polymer material synthesis. The structure formula is shown in the description, wherein n is 10-200. The 1, 11-undecanedioic diamide and the terephthalic acid are taken as the raw materials and the synthetic process is finished in a drum type reaction kettle through a one-pot method. By adopting the method, the reaction devices and the synthetic steps are few, the reaction time is short, the polymerization temperature is low, and the method is pollution-free and suitable for the large-scale industrial production. The PA11T produced by the process is excellent in performance and has a good market prospect in the industries such as the electric products and the automobiles.
Owner:ZHENGZHOU UNIV +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products